This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
U.S. Manufacturing Thriving Amid Supply Bottleneck: 5 Picks
by Nalak Das
We have narrowed down our search to five manufacturing stocks with strong growth potential for 2021. These are CAT, DE, PH, ITW and XYL.
Is John Hancock Multifactor Mid Cap ETF (JHMM) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JHMM
Should You Invest in the Global X U.S. Infrastructure Development ETF (PAVE)?
by Zacks Equity Research
Sector ETF report for PAVE
Kadant's (KAI) Board Okays Quarterly Dividend & Share Buyback
by Zacks Equity Research
Kadant (KAI) to reward shareholders with quarterly dividend payouts and share buybacks under a newly approved $20-million share-buyback program. This underpins its strong cash and financial positions.
Chart Industries (GTLS) Enters Into Partnership With Cryomotive
by Zacks Equity Research
Chart Industries' (GTLS) partnership with Cryomotive will help it expand its hydrogen addressable market by $100 million in the next five years.
Reasons Why it is Worth Buying Parker-Hannifin (PH) Stock Now
by Zacks Equity Research
Parker-Hannifin (PH) to gain from the healthy prospects in Industrial segment, cost-control measures, buyouts and solid product offerings. Also, its Win Strategy and rewards to shareholders bode well.
Parker-Hannifin (PH) to Gain From Healthy Demand Amid Cost Woes
by Zacks Equity Research
Parker-Hannifin (PH) to gain from improving product demand and cost actions. The persistence of weakness in Aerospace Systems, and realignment and other expenses might hurt.
The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp
Top Stock Reports for Nike, CVS Health & American Tower
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), CVS Health Corporation (CVS), and American Tower Corporation (AMT).
4 Stocks to Outshine the Thriving Industrial Manufacturing Industry
by Zacks Equity Research
The Zacks Manufacturing - General Industrial industry seems to be gaining from rise in economic activities, higher orders and technological advancement in manufacturing processes. Four stocks, ITW, PH, XYL and GGG, are the likely outperformers from the industry.
Parker-Hannifin (PH) Beats on Q3 Earnings, Raises 2021 View
by Zacks Equity Research
Parker-Hannifin's (PH) third-quarter fiscal 2021 earnings rise y/y on sales and margin improvement. It increases projections for fiscal 2021.
Parker-Hannifin (PH) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 9.60% and 0.98%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
5 Big Cap Earnings Superstars
by Tracey Ryniec
It's not easy for companies to beat on earnings nearly every quarter for years but these five are doing it.
Parker-Hannifin (PH) to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Parker-Hannifin's (PH) Q3 earnings are likely to have gained from strength across its end-markets and acquired assets. Weak aerospace end market might have dragged its performance.
Will Illinois Tool (ITW) Keep Its Earnings Streak Alive in Q1?
by Zacks Equity Research
Illinois Tool (ITW) Q1 results to reflect gains from solid product offerings, diverse businesses, improving manufacturing activities and enterprise strategy. Pandemic woes are likely to have hurt.
Should You Buy Parker-Hannifin (PH) Ahead of Earnings?
by Zacks Equity Research
Parker-Hannifin (PH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
Parker-Hannifin (PH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Parker-Hannifin (PH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
This 1 Industrial Products Stock Could Beat Earnings: Why It Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Parker-Hannifin (PH) Exhibits Solid Prospects, Risks Persist
by Zacks Equity Research
Parker-Hannifin (PH) is likely to benefit from its unique Win Strategy, improving product demand and acquisitions. However, high realignment expenses and high debt level remain concerning.
Why the Earnings Surprise Streak Could Continue for Parker-Hannifin (PH)
by Zacks Equity Research
Parker-Hannifin (PH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
If You Invested $1000 in Parker-Hannifin 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Here's How Much You'd Have If You Invested $1000 in Parker-Hannifin a Decade Ago
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
If You Invested $1000 in Parker-Hannifin 10 Years Ago, This Is How Much You'd Have Now
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
If You Invested $1000 in Parker-Hannifin a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.